NYSE:TAK Takeda Pharmaceutical Q2 2027 Earnings Report $17.87 +0.01 (+0.04%) Closing price 10/2/2026 03:59 PM EasternExtended Trading$18.14 +0.27 (+1.49%) As of 10/2/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast Takeda Pharmaceutical EPS ResultsActual EPSN/AConsensus EPS $0.15Beat/MissN/AOne Year Ago EPSN/ATakeda Pharmaceutical Revenue ResultsActual RevenueN/AExpected Revenue$7.31 billionBeat/MissN/AYoY Revenue GrowthN/ATakeda Pharmaceutical Announcement DetailsQuarterQ2 2027Date10/29/2026TimeBefore Market OpensConference Call DateThursday, October 29, 2026Conference Call Time2:00AM ETConference Call ResourcesEarnings HistoryCompany Profile Takeda Pharmaceutical Earnings HeadlinesReviewing Takeda Pharmaceutical (NYSE:TAK) and RYTHM (NASDAQ:RYM)October 2 at 5:46 AM | americanbankingnews.comAlpha Cognition (NASDAQ:ACOG) & Takeda Pharmaceutical (NYSE:TAK) Critical ContrastOctober 2 at 4:45 AM | americanbankingnews.comTicker Revealed: Pre-IPO Access to "Next Elon Musk" CompanyWe’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it. | Banyan Hill Publishing (Ad)Takeda (TSE:4502) Stock Looks Below Fair Value Even After A 120% RunOctober 1 at 6:29 PM | finance.yahoo.comCorus International Receives $6.4 Million Grant From Takeda to Reduce Climate-Related Health Risks in NepalOctober 1 at 1:28 PM | tmcnet.comWill Zasocitinib’s Phase 3 Outperformance Reshape Takeda Pharmaceutical's (TSE:4502) Immunology-Driven Pipeline NarrativeOctober 1 at 1:28 PM | finance.yahoo.comSee More Takeda Pharmaceutical Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Takeda Pharmaceutical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Takeda Pharmaceutical and other key companies, straight to your email. Email Address About Takeda PharmaceuticalTakeda Pharmaceutical (NYSE:TAK) Company Limited is a global biopharmaceutical company headquartered in Tokyo, Japan. The company researches, develops, manufactures and commercializes prescription medicines and vaccines, with a focus on gastrointestinal and inflammatory diseases, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. Takeda’s portfolio includes treatments such as Entyvio for inflammatory bowel disease, Takhzyro for hereditary angioedema, Iclusig and Ninlaro for certain blood cancers, and Trintellix for major depressive disorder. The company also develops plasma-derived therapies and vaccines through its research and manufacturing operations. Founded in Osaka in 1781 by Chobei Takeda I, Takeda has evolved from a traditional Japanese medicine business into a multinational biopharmaceutical company. Its medicines and services are available in Japan, the United States, Europe and other markets worldwide. Takeda’s global expansion was significantly strengthened by its acquisition of Shire plc, completed in 2019. Christophe Weber has served as the company’s president and chief executive officer since 2014.View Takeda Pharmaceutical ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Time to Nibble on MCD Stock After it Enters Oversold Territory?McCormick Stock Trades Cheap, Offers Dividend Growth and Unilever Deal UpsideMicron’s Earnings Reveal Why the AI Memory Boom May Last LongerAnthropic's IPO Could Put Amazon's and Alphabet's Paper Profits to the TestBoeing’s Fighter Victory Opens the Door to Decades of Defense RevenueCorning and AT&T's $3 Billion Fiber Deal Reveals Where AI Spending Goes NextTarget's Holiday Blitz: Slashing Prices to Capture Market Share Upcoming Earnings PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
